Recent ALEC News
- Alector to Participate in Upcoming Healthcare Conferences • GlobeNewswire Inc. • 05/09/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:15:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:10:18 PM
- Alector Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/08/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 11:00:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 11:00:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 11:00:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 11:00:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/02/2024 12:52:27 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/02/2024 12:50:30 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/02/2024 12:49:23 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/02/2024 12:48:00 AM
- Alector to Participate in Upcoming Healthcare Conferences • GlobeNewswire Inc. • 02/28/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/27/2024 09:41:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:10:24 PM
- Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/27/2024 09:05:00 PM
- Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call • GlobeNewswire Inc. • 02/20/2024 09:05:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/08/2024 11:59:02 PM
- Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease • GlobeNewswire Inc. • 02/08/2024 12:00:00 PM
- FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN) • GlobeNewswire Inc. • 02/07/2024 12:00:00 PM
- Alector Announces Closing of Public Offering • GlobeNewswire Inc. • 01/19/2024 02:20:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 11:09:31 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/19/2024 11:04:39 AM
- Alector Announces Pricing of Public Offering of Common Stock • GlobeNewswire Inc. • 01/17/2024 01:54:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 09:04:53 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM